- Home
- RAPT vs LPTH Comparison
RAPT vs LPTH Comparison
Compare RAPT & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | LPTH |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 563.1M |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | RAPT | LPTH |
|---|---|---|
| Price | $58.00 | $11.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $56.22 | $13.33 |
| AVG Volume (30 Days) | ★ 4.6M | 2.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $37,202,630.00 |
| Revenue This Year | N/A | $81.01 |
| Revenue Next Year | N/A | $25.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.26 |
| 52 Week Low | $0.71 | $1.61 |
| 52 Week High | $58.02 | $15.24 |
Technical Indicators
Market Signals| Indicator | RAPT | LPTH |
|---|---|---|
| Relative Strength Index (RSI) | 78.57 | 51.86 |
| Support Level | $32.00 | $11.03 |
| Resistance Level | N/A | $13.76 |
| Average True Range (ATR) | 0.09 | 1.27 |
| MACD | -0.79 | 0.00 |
| Stochastic Oscillator | 90.91 | 46.78 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.